Fischer to sell its digital mammography intellectual property to Hologic
Fischer Imaging Corp. announced Wednesday it has entered into a definitive agreement to sell to Hologic, Inc. the intellectual property associated with its mammography business and products, including the rights to Fischer's SenoScan digital mammography and MammoTest stereotactic breast biopsy systems, according to a release.

Under the terms of the agreement, Hologic has agreed to acquire Fischer's mammography intellectual property for a cash purchase price of $32 million, among other details. The acquisition is expected to close in 90-120 days and is subject to customary closing conditions and the approval of Fischer's stockholders.

The agreement will allow Fischer to continue to service the installed base of SenoScan and MammoTest systems with its existing service organization and to maintain its associated contractual obligations.